Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial
Open Access
- 26 May 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 9 (5) , e0003796
Abstract
Schistosoma mansoni infection is proven to be a major health problem of preschool-age children in sub-Saharan Africa, yet this age category is not part of the schistosomiasis control program. The objective of this study was to compare the impact of single and double dose praziquantel (PZQ) treatment on cure rates (CRs), egg reduction rates (ERRs) and re-infection rates 8 months later, in children aged 1-5 years living along Lake Victoria, Uganda. Infected children (n= 1017) were randomized to receive either a single or double dose of PZQ. Initially all children were treated with a single standard oral dose 40 mg/kg body weight of PZQ. Two weeks later a second dose was administered to children in the double dose treatment arm. Side effects were monitored at 30 minutes to 24 hours after each treatment. Efficacy in terms of CRs and ERRs for the two treatments was assessed and compared 1 month after the second treatment. Re-infection with S. mansoni was assessed in the same children 8 months following the second treatment. CRs were non-significantly higher in children treated with two 40 mg/kg PZQ doses (85.5%; 290/339) compared to a single dose (83.2%; 297/357). ERRs were significantly higher in the double dose with 99.3 (95%CI: 99.2-99.5) compared with 98.9 (95%CI: 98.7-99.1) using a single dose, (P = 0.01). Side effects occurred more frequently during the first round of drug administration and were mild and short-lived; these included vomiting, abdominal pain and bloody diarrhea. Overall re-infection rate 8 months post treatment was 44.5%. PZQ is efficacious and relatively safe to use in preschool-age children but there is still an unmet need to improve its formulation to suit small children. Two PZQ doses lead to significant reduction in egg excretion compared to a single dose. Re-infection rates with S. mansoni 8 months post treatment is the same among children irrespective of the treatment regimen. Intestinal schistosomiasis is a parasitic water borne neglected tropical disease of considerable public health relevance in the tropics and subtropics. In Uganda, approximately 20 million people are at risk of being infected with S. mansoni, which causes intestinal schistosomiasis, and 4 million individuals are estimated to be infected. Currently, schistosomiasis control using PZQ chemotherapy is mainly focusing on school-age children (age 6–19 years) and to those adults considered to have the highest risk of infection. So far preschool-age children are not targeted in schistosomiasis preventive chemotherapy campaigns due to the limited documentation on the safety of PZQ in this age group. However, a number of studies have revealed that children less than 6 years of age get infected with S. mansoni usually through bathing, playing or swimming in schistosome-infested waters and are at higher risk of infection than previously thought. This study compared efficacy of PZQ treatment in terms of CRs and ERRs using a single and double dose among children aged 1–5 years, living along Lake Victoria in eastern Uganda. The effect of the two different regimes on S. mansoni re-infection 8 months post treatment was also assessed.Keywords
This publication has 67 references indexed in Scilit:
- A Very High Infection Intensity of Schistosoma mansoni in a Ugandan Lake Victoria Fishing Community Is Required for Association with Highly Prevalent Organ Related MorbidityPLOS Neglected Tropical Diseases, 2013
- Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobiumPLOS Neglected Tropical Diseases, 2012
- A Fresh Insight into Transmission of Schistosomiasis: A Misleading Tale of Biomphalaria in Lake VictoriaPLOS ONE, 2011
- Influence of Exposure History on the Immunology and Development of Resistance to Human Schistosomiasis MansoniPLOS Neglected Tropical Diseases, 2010
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis TreatmentPLOS Neglected Tropical Diseases, 2009
- Optimizing oral medications for childrenClinical Therapeutics, 2008
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006
- Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and MalariaPLOS Medicine, 2006
- “Rapid-Impact Interventions”: How a Policy of Integrated Control for Africa's Neglected Tropical Diseases Could Benefit the PoorPLOS Medicine, 2005